Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €128.90 EUR
Change Today -0.20 / -0.15%
Volume 138.0
As of 3:47 AM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAY) Snapshot

Open
€128.90
Previous Close
€129.10
Day High
€129.20
Day Low
€128.60
52 Week High
03/18/15 - €148.20
52 Week Low
08/8/14 - €94.40
Market Cap
106.6B
Average Volume 10 Days
1.4K
EPS TTM
--
Shares Outstanding
826.9M
EX-Date
05/28/15
P/E TM
--
Dividend
€2.25
Dividend Yield
1.75%
Current Stock Chart for BAYER AG-REG (BAY)

bayer ag-reg (BAY) Related Bloomberg News

View More Bloomberg News

bayer ag-reg (BAY) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as anticoagulants; medicines to treat hemophilia, multiple sclerosis, cancer, eye diseases, pulmonary hypertension, high blood pressure, and infectious diseases; and contraceptives, as well as provides consumer health products, including over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; and contrast agent injection systems for diagnostic and therapeutic medical procedures in X-ray, computed tomography, and magnetic resonance imaging. The CropScience segment offers products in the areas of seeds and plant traits, and crop protection; and products for use in gardens and non-agricultural pest control, as well as green industry. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and specialty chemicals; and selected inorganic basic chemicals. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

119,478 Employees
Last Reported Date: 04/30/15
Founded in 1863

bayer ag-reg (BAY) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €3.2M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €520.0K
Chief Strategy & Portfolio Officer and Member...
Total Annual Compensation: €2.0M
Labor Director and Member of Management Board
Total Annual Compensation: €1.6M
Member of Management Board, Chief Medical Off...
Total Annual Compensation: €1.4M
Compensation as of Fiscal Year 2014.

bayer ag-reg (BAY) Key Developments

Bayer To Float Covestro In 2016

Bayer AG (DB:BAYN) announced that the new name of its MaterialScience business will be Covestro and it intends to float Covestro on the stock market by mid-2016 at the latest.

Bayer Announces to Spend USD 3.4 Million to Expand Manufacturing Capacity

Bayer announced that it plans to spend USD 3.4 million this year to expand manufacturing capacity for effervescents in Indonesia. The new plant is expected to start production in 2016 and boost the production capacity of the company's effervescent plant to 45 million tubes annually from 36.3 million tubes currently. The plans follow the company's investment of USD 8.8 million in its Indonesia-based manufacturing since early 2014.

Bayer and AGCO Collaborates with Other Partners to Launched Future Farm Project in Lusaka, Zambia

Bayer and AGCO, in collaboration with other partners have launched a Future Farm project in Lusaka, Zambia. The Future Farm project will focus on the development of the future farm concept and agricultural training in Zambia, by training farmers in seeding, crop projection, mechanization and food projection. The project is also aimed at driving the mutual development of community projects on the farm and in the region - with a particular focus on maize, soy and wheat. As part of the agreement, Bayer is poised to bring innovation to the project. The company will focus on providing training on pest, weed and disease identification and will also supply and provide education regarding the responsible use of crop protection remedies to both small scale and commercial farmers. Bayer will also leverage local projects and employees to bring together expertise and the partners necessary to develop the future farm training centre concept while also coordinating the agriculture value chain through targeted demonstrations and solutions. AGCO will focus on solutions, providing training on mechanization and food projection, new innovation and assist with the identification of other organizations that may participate in the project and assist with establishing an agricultural supply industry through their worldwide knowledge of agriculture.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAY:IM €128.90 EUR -0.20

BAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $305.71 USD -3.45
Bristol-Myers Squibb Co $65.80 USD -0.68
GlaxoSmithKline PLC 1,438 GBp -3.00
Novo Nordisk A/S kr382.90 DKK -1.70
Sanofi €90.19 EUR +0.55
View Industry Companies
 

Industry Analysis

BAY

Industry Average

Valuation BAY Industry Range
Price/Earnings 33.2x
Price/Sales 2.5x
Price/Book 5.0x
Price/Cash Flow 33.2x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.